Display options
Cite
Atiyeh BS, Gunn SW, Dibo SA. Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)*. Ann Burns Fire Disasters. 2008;21(3):119-23
Atiyeh, B. S., Gunn, S. W., & Dibo, S. A. (2008). Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)*. Annals of burns and fire disasters, 21(3), 119-23.
Atiyeh, B S, et al. "Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)*." Annals of burns and fire disasters vol. 21,3 (2008): 119-23.
Atiyeh BS, Gunn SW, Dibo SA. Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)*. Ann Burns Fire Disasters. 2008 Sep 30;21(3):119-23. PMID: 21991122; PMCID: PMC3188173.
Copy Download .nbib Format: NLM
Share it on

Ann Burns Fire Disasters. 2008 Sep 30;21(3):119-23.

Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)*.

Annals of burns and fire disasters

B S Atiyeh, S W A Gunn, S A Dibo

Affiliations

  1. General Secretary, Mediterranean Council for Burns and Fire Disasters, Clinical Professor, Division Plastic and Reconstructive Surgery, American University of Beirut Medical Center, Beirut, Lebanon.

PMID: 21991122 PMCID: PMC3188173

Abstract

Severe burn patients are some of the most challenging critically ill patients, with an extreme state of physiological stress and an overwhelming systemic metabolic response. Increased energy expenditure to cope with this insult necessitates mobilization of large amounts of substrate from fat stores and active muscle for repair and fuel, leading to catabolism. The hypermetabolic response can last for as long as nine months to one year after injury and is associated with impaired wound healing, increased infection risks, erosion of lean body mass, hampered rehabilitation, and delayed reintegration of burn survivors into society. Reversal of the hypermetabolic response by manipulating the patient's physiological and biochemical environment through the administration of specific nutrients, growth factors, or other agents, often in pharmacological doses, is emerging as an essential component of the state of the art in severe burn management. Early enteral nutritional support, control of hyperglycaemia, blockade of catecholamine response, and use of anabolic steroids have all been proposed to attenuate hypermetabolism or to blunt catabolism associated with severe burn injury. The present study is a literature review of the proposed nutritional and metabolic therapeutic measures in order to determine evidence-based best practice. Unfortunately, the present state of our knowledge does not allow the formulation of clear-cut guidelines. Only general trends can be outlined which will certainly have some practical applications but above all will dictate future research in the field.

Keywords: METABOLIC; NUTRITIONAL; PATIENTS; PHARMACOLOGICAL MODULATION; Part II

References

  1. Crit Care Med. 2000 Nov;28(11):3606-11 - PubMed
  2. Arch Surg. 1994 Dec;129(12):1301-4; discussion 1304-5 - PubMed
  3. J Exp Med. 2003 Sep 1;198(5):725-36 - PubMed
  4. Ann Surg. 1974 Oct;180(4):653-69 - PubMed
  5. Shock. 2007 Feb;27(2):205-8 - PubMed
  6. J Burn Care Res. 2006 Mar-Apr;27(2):131-9; discussion 140-1 - PubMed
  7. Burns. 2003 Dec;29(8):793-7 - PubMed
  8. Ann Surg. 2003 Mar;237(3):422-8 - PubMed
  9. N Engl J Med. 1996 Dec 5;335(23):1713-20 - PubMed
  10. Crit Care Med. 2001 Jul;29(7):1318-24 - PubMed
  11. Ann Surg. 1994 Sep;220(3):310-6; discussion 316-9 - PubMed
  12. Ann Surg. 2002 Aug;236(2):218-25 - PubMed
  13. Ann Surg. 2001 Apr;233(4):556-64 - PubMed
  14. J Trauma. 1997 Jul;43(1):47-51 - PubMed
  15. Burns. 1991 Aug;17(4):279-81 - PubMed
  16. J Trauma. 2003 Mar;54(3):555-61 - PubMed
  17. Anesthesiology. 1998 Jan;88(1):7-17 - PubMed
  18. Burns. 2001 Aug;27(5):447-52 - PubMed
  19. J Trauma. 2005 Nov;59(5):1148-54 - PubMed
  20. Surgery. 2002 Aug;132(2):341-7 - PubMed
  21. Ann Surg. 2005 Feb;241(2):334-42 - PubMed
  22. J Surg Res. 1999 Jul;85(1):171-7 - PubMed
  23. J Am Coll Surg. 2004 Feb;198(2):243-63 - PubMed
  24. J Appl Physiol (1985). 2003 Jun;94(6):2273-81 - PubMed
  25. J Trauma. 1999 Nov;47(5):904-10; discussion 910-1 - PubMed
  26. J Trauma. 2001 Sep;51(3):540-4 - PubMed
  27. Ann Surg. 2000 Feb;231(2):246-52 - PubMed
  28. Ann Surg. 1996 Jun;223(6):777-87; discussion 787-9 - PubMed
  29. Ann Surg. 1999 May;229(5):713-20; discussion 720-2 - PubMed
  30. Shock. 2003 Apr;19(4):314-20 - PubMed
  31. Cardiovasc Drugs Ther. 2000 Dec;14(6):565-77 - PubMed
  32. J Clin Endocrinol Metab. 1987 Apr;64(4):842-8 - PubMed
  33. Ann Surg. 2004 Apr;239(4):553-60 - PubMed
  34. J Trauma. 2004 Feb;56(2):265-9; discussion 269-71 - PubMed
  35. Ann Surg. 2001 Jun;233(6):827-34 - PubMed
  36. Ann Surg. 2003 Jun;237(6):801-10; discussion 810-1 - PubMed
  37. Surg Clin North Am. 1978 Dec;58(6):1173-87 - PubMed
  38. Expert Opin Pharmacother. 2003 Mar;4(3):369-84 - PubMed
  39. N Engl J Med. 2001 Oct 25;345(17):1223-9 - PubMed
  40. Surgery. 2004 Feb;135(2):196-202 - PubMed
  41. Crit Care Med. 2002 Jan;30(1):83-8 - PubMed
  42. J Surg Res. 1999 May 15;83(2):122-9 - PubMed
  43. Surgery. 2004 Aug;136(2):219-24 - PubMed
  44. Ann Burns Fire Disasters. 2008 Jun 30;21(2):63-72 - PubMed

Publication Types